Study identifier:MA-VA-MEDI3250-1115
ClinicalTrials.gov identifier:NCT01985997
EudraCT identifier:N/A
CTIS identifier:N/A
Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
Observation Safety
Phase 4
Yes
-
All
95000
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: Open Label
Primary Purpose: -
Verified 01 Sept 2016 by MedImmune, LLC
MedImmune, LLC
-
No locations available
Arms | Assigned Interventions |
---|